...play Gyroscope Therapeutics Ltd. and CNS company SwanBio Therapeutics Ltd. remain private; another Syncona company, Orbit Biomedical Ltd....

...handful of gene therapy companies Syncona has launched. The firm created Gyroscope Therapeutics Ltd. and Orbit Biomedical Ltd....

...acquired the Orbit SDS technology when Syncona merged Gyroscope and fellow gene therapy portfolio company Orbit Biomedical Ltd....

...$64.3 Catalent Inc. (NASDAQ:CTLT) Paragon Bioservices Inc. 04/15/19 $1,200.0 NA NA $1,200.0 Gyroscope Therapeutics Ltd. Orbit Biomedical Ltd....

...degeneration (AMD) in Phase I/II testing and its own manufacturing capabilities. Syncona Ltd. (LSE:SYNC) launched Orbit Biomedical Ltd....
...gene therapy delivery system. The combined company will retain Gyroscope’s name. Paul Bonanos, Assistant Editor Gyroscope Therapeutics Ltd. Orbit Biomedical Ltd. Syncona...

...as a single entity. Syncona Ltd. (LSE:SYNC) has decided to merge Gyroscope Therapeutics Ltd. with Orbit Biomedical Ltd....
...manufacturing as well, and in some cases cross-license technologies, he said. Paul Bonanos, Assistant Editor Gyroscope Therapeutics Ltd. Orbit Biomedical Ltd. Syncona...

...deal for a portfolio company. Last week, Syncona launched SwanBio Therapeutics Ltd. (Boston, Mass.) and Orbit Biomedical Ltd....

...deal for a portfolio company. Last week, Syncona launched SwanBio Therapeutics Ltd. (Boston, Mass.) and Orbit Biomedical Ltd....

...Syncona Ltd. (LSE:SYNC) launched SwanBio Therapeutics Ltd. (Boston, Mass.) and Orbit Biomedical Ltd. (Philadelphia, Pa.), a pair of...
...certain gene therapies eligible for the designation last year (see BioCentury, Sept. 14, 2017) . Orbit Biomedical Ltd....
...Philadelphia, Pa. SwanBio Therapeutics Ltd., Boston, Mass. Syncona Ltd. (LSE:SYNC), U.K. Business: Gene/Cell Therapy Paul Bonanos Syncona Partners Orbit Biomedical Ltd. SwanBio...

...Syncona Ltd. (LSE:SYNC) launched SwanBio Therapeutics Ltd. (Boston, Mass.) and Orbit Biomedical Ltd. (Philadelphia, Pa.), a pair of...
...eligible for the designation last year (see BioCentury, Sept. 14, 2017) . Paul Bonanos Syncona Partners Syncona Partners LLP Orbit Biomedical Ltd. SwanBio...